Association of the Dopamine Transporter Gene (DAT1) With Poor Methylphenidate Response

Arranz, 1995, Association between clozapine response and allelic variation in 5-HT2A receptor gene, Lancet, 346, 281, 10.1016/S0140-6736(95)92168-0 Caron, 1996, A mouse knockout, Am J Psychiatry, 153, 1387, 10.1176/ajp.153.11.1387 Comings, 1996, Polygenetic inheritance of psychiatric disorders, 235 Comings, 1991, The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders, JAMA, 266, 1793, 10.1001/jama.266.13.1793 Comings, 1998, Multiple additive associations: a technique for the identification of genes in polygenic disorders, Am J Med Genet, 81, 489 Comings, 1999, Additive effect of three adrenergic genes (ADRA2A, ADRA2C, DBH) on ADHD in subjects with Tourette syndrome with and without learning disabilities, Clin Genet, 55, 160, 10.1034/j.1399-0004.1999.550304.x Comings, 1996, Polygenic inheritance of Tourette syndrome, stuttering, ADHD, conduct and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes—DRD2, DBH and DAT1, Am J Med Genet, 67, 264, 10.1002/(SICI)1096-8628(19960531)67:3<264::AID-AJMG4>3.0.CO;2-N Conners, 1985, Rating scales and checklists for child psychopharmacology, Psychopharmacol Bull, 21, 809 Cook, 1995, Association of attention-deficit disorder and the dopamine transporter gene, Am J Hum Genet, 56, 993 Daly, 1999, Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children, Mol Psychiatry, 4, 192, 10.1038/sj.mp.4000510 Gainetdinov, 1999, Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity, Science, 283, 397, 10.1126/science.283.5400.397 Gill, 1997, Confirmation of association between attention deficit disorder and a dopamine transporter polymorphism, Mol Psychiatry, 2, 311, 10.1038/sj.mp.4000290 Gillis, 1992, Attention deficit disorder in reading-disabled twins: evidence for a genetic etiology, J Abnorm Child Psychol, 20, 343, 10.1007/BF00916694 Giros, 1996, Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking dopamine transporter, Nature, 379, 606, 10.1038/379606a0 Grandy, 1989, The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a Taq IRFLP, Am J Hum Genet, 45, 778 Hungund, 1978, A sensitive gas chromatographic method for the determination of methylphenidate (Ritalin) and its major metabolite alpha-phenyl-2-piperidine acetic acid (ritalinic acid) in human plasma using nitrogen-phosphorous detector, Commun Psychopharmacol, 2, 203 Kleyn, 1998, Genetic variation as a guide to drug development, Science, 281, 1820, 10.1126/science.281.5384.1820 La Veist, 1996, Why we should continue to study race … but do a better job: an essay on race, racism and health, Ethn Dis, 6, 21 LaHoste, 1996, Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder, Mol Psychiatry, 1, 121 Lau, 1997, Association studies do not show an increased frequency of the 7-fold repeat form of the dopamine 4 receptor polymorphisms in children with attention deficit disorder (ADHD) (abstract), Am J Hum Genet, 61, A203 Lawford, 1995, Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele, Nat Med, 1, 337, 10.1038/nm0495-337 Richardson, 1988, Effects of methylphenidate dosage in hyperactive reading-disabled children, II: reading achievement, J Am Acad Child Adolesc Psychiatry, 27, 78, 10.1097/00004583-198801000-00012 Rowe, 1998, Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder, Mol Psychiatry, 3, 419, 10.1038/sj.mp.4000432 Seeman, 1998, Anti-hyperactivity medication: methylphenidate and amphetamine, Mol Psychiatry, 3, 386, 10.1038/sj.mp.4000421 Sherman, 1997, Attention-deficit hyperactivity disorder dimensions: a twin study of inattention and impulsivity-hyperactivity, J Am Acad Child Adolesc Psychiatry, 36, 745, 10.1097/00004583-199706000-00010 Sherman, 1997, Twin concordance for attention deficit hyperactivity disorder: a comparison of teachers' and mothers' reports, Am J Psychiatry, 154, 532, 10.1176/ajp.154.4.532 Smeraldi, 1998, Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine, Mol Psychiatry, 3, 508, 10.1038/sj.mp.4000425 Stevenson, 1992, Evidence for a genetic etiology in hyperactivity, Behav Genet, 22, 337, 10.1007/BF01066665 Thapar, 1995, Childhood hyperactivity scores are highly heritable and show sibling competition effects: twin study evidence, Behav Genet, 25, 537, 10.1007/BF02327577 Vandenbergh, 1992, A human dopamine transporter predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic Taq IRFL Ps, Mol Brain Res, 15, 161, 10.1016/0169-328X(92)90165-8 Van Tol, 1992, Multiple dopamine D4 receptor variants in human population, Nature, 358, 149, 10.1038/358149a0 Waldman, 1998, Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity, Am J Hum Genet, 63, 1767, 10.1086/302132 Winsberg, 1987, Is there dose-dependent tolerance associated with chronic methylphenidate therapy in hyperactive children: oral dose and plasma considerations, Psychopharmacol Bull, 23, 107 Winsberg, 1997, Mismatch negativity in hyperactive children: effects of methylphenidate, Biol Psychiatry, 42, 423 Winsberg, 1982, Methylphenidate oral dose plasma concentrations and behavior response in children, Psychopharmacology, 76, 329, 10.1007/BF00449120